Wells Fargo & Company NEUMORA THERAPEUTICS INC. Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
6,826
Previous 45,720 85.07%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-38,894 Reduced 85.07%
6,826 $0
Q1 2025

May 13, 2025
SELL
N/A
-24,933 Reduced 35.29%
45,720 $0
Q4 2024

Feb 12, 2025
BUY
N/A
13,196 Added 22.97%
70,653 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-1,023 Reduced 1.75%
57,457 $0
Q2 2024

Aug 13, 2024
BUY
N/A
23,537 Added 67.36%
58,480 $0
Q1 2024

May 10, 2024
BUY
N/A
7,588 Added 27.74%
34,943 $0
Q4 2023

Feb 09, 2024
BUY
N/A
27,355 New
27,355 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email